News Sentiment

SYRE sentiment intelligence

Spyre Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 42 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 97.74 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 34

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+12.8% over one week, +21.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Why Spyre Therapeutics (SYRE) Stock Is Up Today

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 12.8% Price confirming higher
Trend fit Trend active 21.0% over four weeks
Fair value 237.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 34
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 34
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 11
MT Newswires 6
simplywall.st 3
Quiver Quantitative 2
Seeking Alpha 2
PR Newswire 2
ChartMill 1

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 10
Analyst action 2
Deals and strategy 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 42